Genelux Corp. (GNLX)
2.58
+0.02
(+0.78%)
USD |
NASDAQ |
Apr 02, 09:53
Genelux Total Liabilities (Quarterly) : 7.483M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CorMedix, Inc. | 472.32M |
| Arcutis Biotherapeutics, Inc. | 243.49M |
| MBX Biosciences, Inc. | 15.92M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Agenus, Inc. | 504.66M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.03M |
| Shareholders Equity (Quarterly) | 11.54M |
| Debt to Equity Ratio | 0.146 |
| Current Ratio | 2.430 |
| Net Debt Paydown Yield | 0.04% |